Low-flow low-gradient AS: confirm severity before choosing TAVI or SAVR
A 73-year-old with classical low-flow low-gradient AS and reduced LVEF. Walking through why severity confirmation must come before intervention approach — and what confirmatory testing reveals.
Clinical scenario
Classical LFLG AS with reduced LVEF — is this truly severe AS?
LFLG AS is not a final diagnosis. It is a warning pattern that requires severity confirmation before any intervention decision moves forward.
Clinical scenario
73-year-old man. Exertional dyspnea, NYHA class II–III. Echo: Vmax 2.9 m/s, mean gradient 27 mmHg, AVA 0.88 cm², LVEF 36%, SVI 26 mL/m², dilated LV. History of hypertension and type 2 diabetes. No prior cardiac history.
Why this case is difficult
The danger is to treat AVA alone as the answer. AVA below 1.0 cm² suggests severe AS. But in a low-flow state, the valve may not open fully even if the anatomical stenosis is not truly severe — the result is a small calculated valve area paired with a low gradient.
That creates two very different possibilities.
Possibility 1: true severe AS
The valve is truly tight. The reduced LVEF may be partly caused by afterload mismatch from severe AS. If confirmed, AVR may improve symptoms and possibly LV function.
Possibility 2: pseudo-severe AS
The primary problem is cardiomyopathy — ischemic, hypertensive, diabetic, or idiopathic. Flow is low, so the valve looks smaller than it really is. In this case, replacing the valve may add procedural risk without solving the main problem.
What the AS Severity Tool should say
Not: 'Severe AS — proceed to AVR.' The correct output is: 'Classical LFLG AS with reduced LVEF — confirm true severity before choosing intervention.' That distinction is the whole point of this case.
Why not rush straight to TAVI or SAVR?
Because the intervention decision depends on whether the AS is truly severe. If the patient has pseudo-severe AS, replacing the valve may not help — the main disease is the ventricle, not the valve. If the patient has true severe AS, classical LFLG with reduced EF is a high-risk phenotype where delay also carries risk. The answer is not to wait. The answer is to not skip confirmation.
Confirmatory testing
Low-dose dobutamine stress echocardiography
Low-dose dobutamine increases contractility and flow. The goal is to see what happens to both gradient and valve area when flow increases.
- Flow increases, mean gradient ≥40 mmHg, AVA remains ≤1.0 cm²: supports true severe AS.
- Flow increases, AVA rises to >1.0 cm², gradient remains non-severe: suggests pseudo-severe AS — the valve was functionally small due to low flow.
- Flow does not increase sufficiently: DSE is inconclusive; CT calcium scoring becomes more important.
CT aortic valve calcium scoring
CT calcium scoring asks a different question: is the valve anatomically calcified enough to explain severe AS? It is not flow-dependent, which makes it useful when DSE is inconclusive or contractile reserve is absent.
- Thresholds commonly used to support severe AS: ≥2000 AU in men, ≥1200 AU in women.
- Values above 3000 AU (men) or 1600 AU (women) are associated with highly probable severe AS in ESC probability categories.
Reassess after clinical optimization
If the patient is tachycardic, hypertensive, volume overloaded, or decompensated, the echo may not represent a stable baseline. Treat congestion, control blood pressure, optimize rhythm and heart rate, then reassess. This does not replace severity confirmation — it makes confirmation more reliable.
What if there is no contractile reserve?
If stroke volume does not increase with dobutamine, gradient may stay low because flow never rises — that does not prove the AS is mild. CT calcium scoring becomes particularly important in this situation. Absent contractile reserve predicts higher procedural risk and worse prognosis, but does not automatically exclude AVR if the valve is clearly and anatomically severe. These patients require Heart Team discussion.
Two mistakes to avoid
First: treating pseudo-severe AS with AVR — the patient gets procedural risk without clear benefit. Second: dismissing true severe AS because the gradient is low — LFLG AS with reduced EF is a high-risk phenotype. The safe path is structured severity confirmation before choosing the approach.
Practical summary
- Recognize the discordant pattern: AVA in severe range, gradient non-severe, flow low.
- Use DSE and/or CT calcium scoring to confirm true severity.
- Optimize heart failure, blood pressure, rhythm, and volume status before reassessment.
- True severe AS confirmed: Heart Team discussion for TAVI vs SAVR.
- Pseudo-severe AS likely: treat cardiomyopathy and reassess.
The tool identifies classical LFLG AS with reduced LVEF. What is the next best step?
- 1.Proceed directly to TAVI⚠ Not recommended
AS severity is not confirmed. TAVI may be appropriate later, but this step skips the key diagnostic question.
- 2.Confirm severity with low-dose dobutamine stress echo and/or CT calcium scoring before choosing TAVI or SAVR✓ Recommended
This matches the ACC/AHA 2020 approach to suspected LFLG severe AS with reduced LVEF.
- 3.Optimize medical therapy and reassess in 3–6 months△ Consider
Reasonable if the patient is clinically stable and decompensation is being treated — but does not replace severity confirmation.
Teaching points
- LFLG AS is a phenotype, not a final diagnosis.
- AVA alone can overcall severe AS when flow is low — the calculated area may be small because the valve never opened fully, not because it cannot.
- In classical LFLG AS, the key clinical distinction is true severe AS versus pseudo-severe AS.
- Low-dose dobutamine stress echo tests how gradient and valve area behave when flow increases — a rising gradient with stable AVA supports true severity; a rising AVA suggests pseudo-severe.
- CT calcium scoring provides a flow-independent structural assessment — especially useful when DSE is inconclusive or contractile reserve is absent.
- Absent contractile reserve increases procedural risk but does not automatically exclude AVR if anatomical severity is confirmed.
- Low gradient does not mean low risk — LFLG AS with reduced EF is a high-stakes presentation.
- The right move is not to delay care. It is to confirm severity before choosing the intervention.
Apply this in practice
After confirming severity, classify the phenotype in the AS Severity Tool.
Return to AS Severity Tool